ID: ALA2368659

Max Phase: Preclinical

Molecular Formula: C12H12N2O4

Molecular Weight: 248.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc2cn([C@H]3C=C[C@@H](CO)O3)c(=O)nc2o1

Standard InChI:  InChI=1S/C12H12N2O4/c1-7-4-8-5-14(12(16)13-11(8)17-7)10-3-2-9(6-15)18-10/h2-5,9-10,15H,6H2,1H3/t9-,10+/m0/s1

Standard InChI Key:  VXPJYTUKTZLBBQ-VHSXEESVSA-N

Associated Targets(non-human)

Deoxynucleoside kinase 95 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.24Molecular Weight (Monoisotopic): 248.0797AlogP: 0.74#Rotatable Bonds: 2
Polar Surface Area: 77.49Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 0.13CX LogD: 0.13
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.79Np Likeness Score: 0.86

References

1. Li Y, Soni PB, Liu L, Zhang X, Liotta DC, Lutz S..  (2010)  Synthesis of fluorescent nucleoside analogs as probes for 2'-deoxyribonucleoside kinases.,  20  (3): [PMID:20060716] [10.1016/j.bmcl.2009.12.097]

Source